Effects of Antisense Oligonucleotide on Lung Function in Asthma
Author Information
Author(s): Torres Rosa, Herrerias Aida, Serra-Pagès Mariona, Roca-Ferrer Jordi, Pujols Laura, Marco Alberto, Picado César, de Mora Fernando
Primary Institution: Hospital Clínic, IDIBAPS, Universitat de Barcelona
Hypothesis
Does selective impairment of COX-2 production improve inflammation and affect airway function in asthma?
Conclusion
The study found that while inflammation improved with COX-2 impairment, airway hyperreactivity worsened.
Supporting Evidence
- COX-2 mRNA and protein expression were significantly reduced in treated mice.
- Airway hyperreactivity increased in COX-2 antisense oligonucleotide-treated mice.
- Inflammation was reduced by 50-55% in COX-2 antisense oligonucleotide-treated mice.
Takeaway
Researchers used a special treatment to reduce a protein in the lungs that usually helps with asthma. They found that this made the inflammation better but made it harder to breathe.
Methodology
BALBc mice were sensitized to house dust mite and treated with an antisense oligonucleotide to impair COX-2 production, followed by assessments of lung function and inflammation.
Potential Biases
Potential bias in the interpretation of results due to the use of a single animal model.
Limitations
The study was conducted in a mouse model, which may not fully replicate human asthma conditions.
Participant Demographics
Adult female BALBc mice aged 6 to 8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website